LEGN logo

Legend Biotech (LEGN) EBITDA

annual EBITDA:

-$113.16M+$364.71M(+76.32%)
December 31, 2024

Summary

  • As of today (June 29, 2025), LEGN annual EBITDA is -$113.16 million, with the most recent change of +$364.71 million (+76.32%) on December 31, 2024.
  • During the last 3 years, LEGN annual EBITDA has risen by +$279.22 million (+71.16%).
  • LEGN annual EBITDA is now -76045.64% below its all-time high of $149.00 thousand, reached on December 31, 2018.

Performance

LEGN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

quarterly EBITDA:

-$88.87M-$141.33M(-269.41%)
March 31, 2025

Summary

  • As of today (June 29, 2025), LEGN quarterly EBITDA is -$88.87 million, with the most recent change of -$141.33 million (-269.41%) on March 31, 2025.
  • Over the past year, LEGN quarterly EBITDA has dropped by -$40.28 million (-82.89%).
  • LEGN quarterly EBITDA is now -269.41% below its all-time high of $52.46 million, reached on December 31, 2024.

Performance

LEGN quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

TTM EBITDA:

-$153.44M-$40.28M(-35.60%)
March 31, 2025

Summary

  • As of today (June 29, 2025), LEGN TTM EBITDA is -$153.44 million, with the most recent change of -$40.28 million (-35.60%) on March 31, 2025.
  • Over the past year, LEGN TTM EBITDA has increased by +$271.35 million (+63.88%).
  • LEGN TTM EBITDA is now -1199.00% below its all-time high of -$11.81 million, reached on March 31, 2019.

Performance

LEGN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

LEGN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+76.3%-82.9%+63.9%
3 y3 years+71.2%-185.9%+54.3%
5 y5 years+9.4%-102.2%+5.1%

LEGN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+76.3%-269.4%+53.6%-35.6%+69.0%
5 y5-yearat high+76.3%-269.4%+53.6%-35.6%+69.0%
alltimeall time<-9999.0%+76.3%-269.4%+53.6%-1199.0%+69.0%

LEGN EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$88.87M(-269.4%)
-$153.44M(+35.6%)
Dec 2024
-$113.16M(-76.3%)
$52.46M(-147.7%)
-$113.16M(-62.4%)
Sep 2024
-
-$109.91M(+1444.3%)
-$301.26M(+24.0%)
Jun 2024
-
-$7.12M(-85.4%)
-$243.00M(-42.8%)
Mar 2024
-
-$48.59M(-64.2%)
-$424.79M(-11.1%)
Dec 2023
-$477.87M(+14.7%)
-$135.64M(+162.6%)
-$477.87M(+2.1%)
Sep 2023
-
-$51.65M(-72.7%)
-$467.85M(-5.0%)
Jun 2023
-
-$188.91M(+85.8%)
-$492.64M(-0.5%)
Mar 2023
-
-$101.68M(-19.1%)
-$495.17M(+16.6%)
Dec 2022
-$416.54M(+6.2%)
-$125.61M(+64.3%)
-$424.57M(+5.1%)
Sep 2022
-
-$76.45M(-60.1%)
-$403.96M(-10.1%)
Jun 2022
-
-$191.43M(+515.9%)
-$449.20M(+33.8%)
Mar 2022
-
-$31.08M(-70.4%)
-$335.60M(-15.9%)
DateAnnualQuarterlyTTM
Dec 2021
-$392.38M(+31.6%)
-$105.01M(-13.7%)
-$399.09M(+12.5%)
Sep 2021
-
-$121.69M(+56.4%)
-$354.69M(+18.2%)
Jun 2021
-
-$77.83M(-17.7%)
-$299.97M(-16.0%)
Mar 2021
-
-$94.56M(+56.0%)
-$356.93M(+16.5%)
Dec 2020
-$298.16M(+138.7%)
-$60.61M(-9.5%)
-$306.31M(-0.3%)
Sep 2020
-
-$66.96M(-50.3%)
-$307.30M(+14.6%)
Jun 2020
-
-$134.79M(+206.7%)
-$268.04M(+65.8%)
Mar 2020
-
-$43.95M(-28.7%)
-$161.70M(+24.8%)
Dec 2019
-$124.89M(<-9900.0%)
-$61.60M(+122.3%)
-$129.57M(+90.6%)
Sep 2019
-
-$27.71M(-2.6%)
-$67.97M(+68.8%)
Jun 2019
-
-$28.45M(+140.8%)
-$40.26M(+240.8%)
Mar 2019
-
-$11.81M
-$11.81M
Dec 2018
$149.00K
-
-

FAQ

  • What is Legend Biotech annual EBITDA?
  • What is the all time high annual EBITDA for Legend Biotech?
  • What is Legend Biotech annual EBITDA year-on-year change?
  • What is Legend Biotech quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Legend Biotech?
  • What is Legend Biotech quarterly EBITDA year-on-year change?
  • What is Legend Biotech TTM EBITDA?
  • What is the all time high TTM EBITDA for Legend Biotech?
  • What is Legend Biotech TTM EBITDA year-on-year change?

What is Legend Biotech annual EBITDA?

The current annual EBITDA of LEGN is -$113.16M

What is the all time high annual EBITDA for Legend Biotech?

Legend Biotech all-time high annual EBITDA is $149.00K

What is Legend Biotech annual EBITDA year-on-year change?

Over the past year, LEGN annual EBITDA has changed by +$364.71M (+76.32%)

What is Legend Biotech quarterly EBITDA?

The current quarterly EBITDA of LEGN is -$88.87M

What is the all time high quarterly EBITDA for Legend Biotech?

Legend Biotech all-time high quarterly EBITDA is $52.46M

What is Legend Biotech quarterly EBITDA year-on-year change?

Over the past year, LEGN quarterly EBITDA has changed by -$40.28M (-82.89%)

What is Legend Biotech TTM EBITDA?

The current TTM EBITDA of LEGN is -$153.44M

What is the all time high TTM EBITDA for Legend Biotech?

Legend Biotech all-time high TTM EBITDA is -$11.81M

What is Legend Biotech TTM EBITDA year-on-year change?

Over the past year, LEGN TTM EBITDA has changed by +$271.35M (+63.88%)
On this page